Literature DB >> 22118177

Neuromyelitis optica and pulmonary tuberculosis: a case-control study.

V Zatjirua1, J Butler, J Carr, F Henning.   

Abstract

SETTING: Neuromyelitis optica (NMO), or Devic's disease, is a rare acute inflammatory disease characterised by demyelination affecting the spinal cord and optic nerves. Although NMO usually occurs in isolation, the association between NMO and active pulmonary tuberculosis (TB) has been suggested by a number of case reports and series.
OBJECTIVE: To investigate the possible association between NMO and TB.
DESIGN: A retrospective case-control study. We included adult patients admitted to our institution with a nal diagnosis of NMO based on accepted criteria between January 1995 and February 2011. Controls were hospital-based and consisted of patients admitted with a diagnosis of Guillain-Barré syndrome.
RESULTS: Fourteen patients met the inclusion criteria, of whom 11 (79%) had a preceding or simultaneous diagnosis of pulmonary TB (PTB). The diagnosis of PTB preceded the onset of NMO by a median time of 4 weeks (range 0-12). Two of the controls were diagnosed with PTB. The odds ratio for the presence of active PTB in the NMO group vs. the control group was 4.6 (95%CI 1.71-15.49).
CONCLUSION: These results indicate an association be- tween NMO and PTB in our population. The most likely mechanism is immune-mediated inflammatory demyelination of the optic nerves and spinal cord triggered by pulmonary infection with Mycobacterium tuberculosis.

Entities:  

Mesh:

Year:  2011        PMID: 22118177     DOI: 10.5588/ijtld.10.0780

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  16 in total

1.  Primary Hepatic Marginal Zone Lymphoma in a Patient with Chronic Hepatitis C.

Authors:  George S Gherlan; Razvan Stoia; Mihaly Enyedi; Camelia Dobrea; Petre I Calistru
Journal:  Maedica (Bucur)       Date:  2016-09

2.  An Uncommon Cause of Longitudinally Extensive Transverse Myelitis.

Authors:  Catalina Coclitu; Athena Mergeani; Teodora Parvu; Octaviana Rusu; Andrei Ciobotaru; Ovidiu Bajenaru; Florina Antochi
Journal:  Maedica (Bucur)       Date:  2016-09

3.  Neuromyelitis optica: atypical clinical and neuroradiological presentation.

Authors:  Alessandra Splendiani; Silvia Mariani; Monica Anselmi; Alessia Catalucci; Ernesto Di Cesare; Massimo Gallucci
Journal:  Neuroradiol J       Date:  2015-02

Review 4.  Neuro-ophthalmic manifestations of tuberculosis.

Authors:  Rebika Dhiman; Subodh Lakra; Prateek Kumar Panda; Naren Hemachandran; Sanjay Sharma; Rohit Saxena
Journal:  Eye (Lond)       Date:  2021-06-14       Impact factor: 3.775

5.  Neuromyelitis optica in a Ugandan woman: a case report.

Authors:  Mark Kaddumukasa; Abdu Musubire; Martin Kaddumukasa; Steven Matovu; Elly Katabira
Journal:  J Med Case Rep       Date:  2013-07-05

6.  Neuromyelitis optica spectrum disorder and active tuberculosis.

Authors:  James Kerr Grieve; Scott Day; David Connell; Jonathan O'Riordan
Journal:  BMJ Case Rep       Date:  2020-01-02

7.  Tubercular longitudinally extensive transverse myelitis (LETM): An enigma for primary care physicians.

Authors:  Kumar Abhishek Anand; Kalyan Kumar Bhowmik; Amit Sarkar; Ritwik Ghosh; Arpan Mandal; Bikash Swaika; Biman Kanti Ray
Journal:  J Family Med Prim Care       Date:  2021-02-27

8.  Longitudinally extensive transverse myelitis with mycobacterium tuberculosis infection.

Authors:  Le Fang; Yushuang Gong; Kai Han; Yalin Lv; Miao Li; Jie Wang
Journal:  Acta Neurol Belg       Date:  2021-07-05       Impact factor: 2.396

9.  Association between neuromyelitis optica and tuberculosis in a Chinese population.

Authors:  Rui Li; Xiaonan Zhong; Wei Qiu; Aimin Wu; Yongqiang Dai; Zhengqi Lu; Xueqiang Hu
Journal:  BMC Neurol       Date:  2014-02-20       Impact factor: 2.474

10.  Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis.

Authors:  Siddharth Sridhar; Jasper Fuk-Woo Chan; Kwok-Yung Yuen
Journal:  BMC Infect Dis       Date:  2014-08-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.